Cranial irradiation and cerebrospinal fluid levels of 6-mercaptopurine in children with acute leukemia
We measured 6-mercaptopurine levels in the cerebrospinal fluid and plasma of 15 children undergoing treatment for acute leukemia. Plasma and cerebrospinal fluid samples obtained by lumbar puncture were collected before, during, and after cranial irradiation in order to evaluate a possible change in blood-brain barrier permeability to orally administered 6-mercaptopurine. Considerable interpatient variability has been observed in both plasma and cerebrospinal fluid 6-mercaptopurine levels. No statistical differences in the 6-mercaptopurine cerebrospinal fluid levels under the three different conditions could be detected. Our data suggest that cranial irradiation does not significantly influence the cerebrospinal fluid levels.
Key words6-Mercaptopurine Cranial irradiation Childhood leukemia
Unable to display preview. Download preview PDF.
- 1.Riehm H, Gadner H, Henze G, Kornhuber B, Langermann H J, Muller-Weihrich S, Schellong G: Acute lymphoblastic leukemia: treatment results in three BFM studies (1970–1981), in Murphy S B, Gilbert J L (eds):Leukemia Research: Advances in Cell Biology and Treatment, pp. 251–263. Elsevier (1983).Google Scholar
- 4.Creutzig U, Ritter J, Riehm H, Langermann H J, Henze G, Kabish H, Niethammer D, Jurgens H, Stollman B, Lasson U, Kaufman U, Loffler H, Schellong G: Improved treatment results in childhood acute myelogeneous leukemia: a report from the German cooperative study AML BFM 78.Blood 65, 298 (1985).PubMedGoogle Scholar
- 8.Clemente C D, Holst E A: Pathological changes in neurons neuroglia and blood brain barrier induced by X irradiation of the head of monkeys.AMA Arch Neurol Psychiat 71, 66 (1954).Google Scholar
- 9.Hayder S, Lafolie P, Bjork O, Ahstrom L, Perteson C: 6-Mercaptopurine in cerebrospinal fluid during oral maintenance therapy of children with acute lymphoblastic leukemia.Med Oncol tumor Pharma-cother 5 (3), 187 (1988).Google Scholar